LA JOLLA PHARMACEUTICAL CO (LJPC) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Net product sales			23.1	10.1
Total revenues [+]	75.7	33.4	23.1	10.1	0.0	0.6	1.1	0.0
Products			23.1	10.1
Revenue growth [+]	126.6%	45.0%	129.3%		-100.0%	-41.7%
Net product sales			129.3%
Cost of goods sold	13.5	7.8	2.4	1.6	-1.6	-0.5	0.8	0.5
Gross profit	62.2	25.6	20.7	8.4	1.6	1.1	0.3	-0.5
Gross margin	82.2%	76.6%	89.6%	83.7%		181.2%	24.3%
Selling, general and administrative [+]	35.4	38.4	45.1	85.2	30.9	16.7	13.9	11.4
General and administrative							13.9	11.4
Research and development	5.0	23.0	85.3	117.3	86.2	62.8	29.1	9.9
Other operating expenses							-0.8	-0.5
EBITDA [+]	23.5	-33.0	-105.2	-189.6	-114.2	-77.6	-41.6	-21.3
EBITDA growth	-171.2%	-68.6%	-44.5%	66.1%	47.0%	86.5%	95.2%	18.9%
EBITDA margin	31.0%	-98.8%	-456.5%	-1885.9%		-12604.2%	-3937.7%
Depreciation	0.1	2.2	4.6	4.4	1.3	0.7	0.3	0.0
EBITA	23.4	-35.2	-109.8	-194.1	-115.4	-78.4	-42.0	-21.3
EBITA margin	30.9%	-105.3%	-476.3%	-1929.7%		-12722.7%	-3970.6%
Amortization of intangibles	1.6	0.6
EBIT [+]	21.8	-35.8	-109.8	-194.1	-115.4	-78.4	-42.0	-21.3
EBIT growth	-160.9%	-67.4%	-43.4%	68.1%	47.3%	86.7%	96.7%	18.9%
EBIT margin	28.8%	-107.2%	-476.3%	-1929.7%		-12722.7%	-3970.6%
Interest expense, net [+]	10.5	9.8	8.6	5.4	-0.6	-0.2
Interest expense	10.5	10.1	10.8	7.3
Interest income	0.0	0.2	2.1	1.9	0.6	0.2
Other income (expense), net [+]	8.3	6.2	1.9				0.1	0.0
Other	0.7	0.0			0.6	0.2	0.1	0.0
Pre-tax income	19.7	-39.4	-116.5	-199.5	-114.8	-78.2	-41.9	-21.3
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.2%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	19.7	-39.4	-116.5	-199.5	-114.8	-78.2	-41.9	-21.3
Net margin	26.0%	-118.0%	-505.4%	-1983.6%		-12692.4%	-3965.2%

Basic EPS [+]	$0.72	($1.44)	($4.30)	($7.85)	($5.41)	($4.54)	($2.68)	($2.00)
Growth	-149.7%	-66.4%	-45.2%	45.0%	19.2%	69.5%	34.0%	-83.6%
Diluted EPS [+]	$0.58	($1.44)	($4.30)	($7.85)	($5.41)	($4.54)	($2.68)	($2.00)
Growth	-139.9%	-66.4%	-45.2%	45.0%	19.2%	69.5%	34.0%	-83.6%

Shares outstanding (basic) [+]	27.4	27.3	27.1	25.4	21.2	17.2	15.7	10.7
Growth	0.4%	0.8%	6.6%	19.8%	23.1%	10.1%	46.7%	592.7%
Shares outstanding (diluted) [+]	34.2	27.3	27.1	25.4	21.2	17.2	15.7	10.7
Growth	25.1%	0.8%	6.6%	19.8%	23.1%	10.1%	46.7%	592.7%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.